Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bfbb3413ffed9e5fe85146e5f2f4023a9> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bfbb3413ffed9e5fe85146e5f2f4023a9 NCIT_P378 "NCI" @default.
- Bfbb3413ffed9e5fe85146e5f2f4023a9 type Axiom @default.
- Bfbb3413ffed9e5fe85146e5f2f4023a9 annotatedProperty IAO_0000115 @default.
- Bfbb3413ffed9e5fe85146e5f2f4023a9 annotatedSource NCIT_C171808 @default.
- Bfbb3413ffed9e5fe85146e5f2f4023a9 annotatedTarget "A gene replacement therapy agent composed of autologous cluster of differentiation 34 (CD34)-positive human hematopoietic stem cells (HSCs) transduced ex vivo with Lenti-D lentiviral vector (LVV), a replication-incompetent, self-inactivating LVV carrying ABCD1 complementary DNA (cDNA) that encodes normal adrenoleukodystrophy protein (ALD protein; ALDP), that can be used to treat early cerebral adrenoleukodystrophy (CALD). Upon administration, elivaldogene autotemcel engrafts in the bone marrow and differentiates into various cell types, including monocytes, that produce functional copies of the ABCD1 cDNA and thus functional ALDP. Functional ALDP degrades very long chain fatty acids (VLCFAs), which prevents accumulation of VLCFAs and may decrease or prevent further inflammation, demyelination and nerve damage. This slows the progression of neurologic dysfunction in patients with early, active cerebral adrenoleukodystrophy (CALD)." @default.